NCT06392308

Brief Summary

Postoperative delirium is a common complication that frequently occurs in elderly patients after surgery. It not only increases the length of hospital stays and healthcare costs but also raises the incidence of postoperative cognitive dysfunction and even mortality. However, the underlying mechanisms of its onset are not yet fully understood. Evidence suggests that smoking can lead to gut microbiota dysbiosis and metabolic dysfunction, and the gut microbiota and its metabolites play a crucial role in cognitive function through the gut-brain axis. Yet, no studies have reported whether smoking could affect the occurrence of postoperative delirium and the quality of postoperative recovery through the gut microbiota. This study aims to observe the incidence of postoperative delirium and the postoperative recovery quality scores between smokers and non-smokers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

4 months

First QC Date

April 26, 2024

Last Update Submit

January 15, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative delirium

    CAM method

    Within 3 days post-surgery

  • Quality of recovery in the first postoperative day

    Quality of recovery is assessed with the Quality of Recovery-15 questionaire in the first postoperative day.

    Up to 24 hours after surgery.

Study Arms (2)

Smoker group

who smoke more than one cigarette per day continuously or cumulatively for six months; more than four times a week but averaging less than one cigarette per day

Other: none intervention

Non-smoker group

never smoke

Other: none intervention

Interventions

No interventions are administered to either group of patients.

Non-smoker groupSmoker group

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients who meet the inclusion criteria are divided into a smoking group and a non-smoking group based on their smoking status. The general information of the patients, perioperative data, and postoperative follow-up data are recorded. By conducting propensity score matching analysis, differences in outcomes due to confounding factors are minimized, and exploratory analysis is performed on the matched patient data to investigate the impact of gut microbiota and metabolism on the incidence of postoperative delirium and the quality of postoperative recovery.

You may qualify if:

  • Age \>60 years;
  • American Society of Anesthesiologists (ASA) preoperative anesthesia classification ASA Grades I and II;
  • Undergoing elective surgery;
  • Patients and their families are able to understand and complete various scoring scales and voluntarily sign informed consent.

You may not qualify if:

  • Mini-Mental State Examination (MMSE) score \<23;
  • Preoperative biochemical tests indicate renal dysfunction or active liver disease;
  • History of definite neurological or psychiatric disorders or history of taking corresponding medications before surgery;
  • History of alcohol abuse or drug dependency;
  • Taking antidepressant medications;
  • American Society of Anesthesiologists (ASA) preoperative anesthesia classification \> Grade II.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated hospital of Nantong University

Nantong, Jiangsu, 226001, China

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Chao-Chao Zhong

    Affiliated Hospital of Nantong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chao-Chao Zhong, M.D.;P.H.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 26, 2024

First Posted

April 30, 2024

Study Start

September 1, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 16, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations